Who invested in PathoVax?
PathoVax's investors include National Science Foundation, MassChallenge and 43North.
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$2.8Mraised across 1 round since 2018, from 1 source
Source recordedSEC filing: $2.8M sold, first sale May 2018
PathoVax's investors include National Science Foundation, MassChallenge and 43North.
PathoVax has raised $2.8M across 1 round since 2018.
PathoVax's most recent round was a Venture of $2.8M in Aug 2018.
Its most recent round, $2.8M in Aug 2018, is also its largest on record.
PathoVax's first round on record, in Aug 2018, was backed by National Science Foundation, MassChallenge and 43North.
PathoVax's latest named round is a Venture, in Aug 2018.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.